Medinice (FRA:77E) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:77E Medinice SA FRA:77E
20 GF Score
Price €17.58
GF Value €0.22
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medinice Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Medinice Valuation Rank Related Terms

FRA:77E
20GF Score
Medinice SA FRA:77E
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medinice (FRA:77E) Overvalued in 2026?

Based on GuruFocus' analysis, Medinice stock appears to be overvalued. The current stock price of €17.58 is trading 7890.9% above its estimated GF Value™ of €0.22. GuruFocus considers Medinice to be Significantly Overvalued.

Key valuation signals for FRA:77E:

  • Valuation Rank:
  • GF Value™: €0.22 vs. price of €17.58 (7890.9% above fair value)
  • GF Score™: 20/100 with 2 warning signs

No single metric tells the full story. See the FRA:77E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medinice Business Description

Other Exchanges ICE:Poland
Address Hankiewicza Street 2, Warszawa, POL, 02-103
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
20GF Score

Get the complete analysis for FRA:77E

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.58
Price
€0.22
GF Value